A comparative study of low dose magnesium sulphate therapy with standard pritchard’s regime in the management of eclampsia

Authors

  • Swarnalatha Mohanapu Department of Obstetrics and Gynecology, SRM Medical College Hospital and Research Centre, Kanchipuram, Tamilnadu-603203, India
  • Sajeethakumari Raveendran Department of Obstetrics and Gynecology, SRM Medical College Hospital and Research Centre, Kanchipuram, Tamilnadu-603203, India
  • Yogashalini Murugaiah Department of Obstetrics and Gynecology, SRM Medical College Hospital and Research Centre, Kanchipuram, Tamilnadu-603203, India
  • Maitrayee Sen Department of Obstetrics and Gynecology, SRM Medical College Hospital and Research Centre, Kanchipuram, Tamilnadu-603203, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20162894

Keywords:

Keywords, Eclampsia, Low dose magnesium sulphate, Pritchard’s regime, Toxicity

Abstract

Background: Eclampsia is one of the most serious and potentially catastrophic complications of pregnancy and still remains a common cause of maternal and perinatal mortality and morbidity in India. Magnesium sulphate is the main stay of treatment in eclampsia and imminent eclampsia. As the margin of safety between therapeutic and toxic levels of magnesium sulphate is narrow, monitoring the serum magnesium levels to assess the criticality of situation is an uphill task in our hospitals, there is a need for modification of dosage of magnesium sulphate in tropical countries. This study compared the efficacy and toxicity of low dose magnesium sulphate regime with the standard pritchard’s regime in eclampsia.

Methods: 50 cases of eclampsia were treated with low dose magnesium sulphate and 50 cases of eclampsia with standard Pritchard’s regime. The recurrence rate of convulsions and magnesium toxicity were analysed.

Results: It was observed that with low dose magnesium sulphate regime, convulsions were controlled in 90% of the cases. With standard pritchard’s regime convulsions were controlled in 96% of patients. The maternal and perinatal mortality and morbidity were comparable in both groups.

Conclusions: Low dose magnesium sulphate therapy is as effective as Pritchard’s regime for controlling convulsions in eclampsia.

References

Ratnam SS, Rao KB, Kumar SA. Management of PIH. Obstetrics and Gynaecology of post graduates. Orient Longman. 2005;1(2):56-67.

Bansal V, Damania KR. Hypertensive disorders in pregnancy, Fernando Arias, Practical Guide to High Risk Pregnancy and Delivery 4th Edition, Elsevier; 2015:218-229.

Gopalan S. Hypertensive disorder of pregnancy, Mudaliar and Menon's clinical obstetrics, 12th edition, Universities Press; 2015:175-179.

Goswami B. Journal of Postgraduate Medicine, Eclampsia in rural India. J Obstet and Gynaecol Ind. 1984;34:1012-5.

Cunningham FG, Leveno KJ. Hypertensive disorders. William's Obstetrics 24th edition, Mc Graw Hill; 2010:755-770.

James DK, Steer PJ, Weiner CP, Gonik B. Asnat Walfisch/Mordechai Hallak, Hypertension, High Risk Pregnancy Management options, 3rd Edition, Elsevier; 2006:784-788.

Malhotra B, Misra R. Hypertensive Disorder in Pregnancy Ian Donald's Practical Obstetric Problems: 6th Edition, BI Publications; 2008:289-304.

Baha M, Sibai. Pregnancy and co existing disease Hypertension, Steven G. Gabbe, Jennifer R. Niebyl, Joe Leigh Simpson, Obstetrics Normal and Problem Pregnancies, 5th Edition, Churchill Livingstone Elsevier; 2007:895-897.

Noor S, Halini M, Faiz NR , Gull F, Akbar N. Magnesium sulphate in the prophylaxis and treatment of eclampsia. J Ayub Med Coll Abbottabad. 2004;16(2):50-4.

Sahu L, Singh S, Tempe A, BC Koner. A randomised comparative study between low dose magnesium sulphate and standard dose regimen for management of eclampsia. Int J Reprod Contracept Obstet Gynecol. 2014;3(1):79-86.

Abdul MA, Nasir UI, Khan N, Yusuf MD. Low dose magnesium sulphate in the control of eclamptic fits, a randomised control trial. Archives Gynecol Obstet. 2013;287:43-6.

Jana N, Dasgupta S, Das AK, Sandra D, Samanta B. Experience of a low dose magnesium sulphate regimen for the management of eclampsia over a decade. Internat J Gyn Obstet. 2013;122(1):13-7.

Suman S, Patil MS, Patil U. Low dose magnesium sulphate therapy for eclampsia and imminent eclampsia regime tailored for Indian women. Jr Obst Gynaecol India. 2003;53(6):540-6.

Begum R, Begum A, Johanson R, Ali MN, Akhter S. A low dose (Dhaka) magnesium sulphate regime for eclampsia. Acta Obstet Gynecol. 2001;80(11):998-1002.

Jayatinath, Sharma R, Mahajan SS. A study on low dose magnesium sulphate regime for eclampsia in a tertiary care teaching hospital in North India. Biomed Pharmacol J. 2013;6(1):29-32.

Bangal V, Kwatra A, Raghav S, Jadhav S. Low dose magnesium sulphate for eclampsia. Pravara Med Rev. 2009;1(3):13-5.

Ekele BA, Muhammed D, Bello LN, Namadina IM. Magnesium sulphate therapy in eclampsia: the Sokoto (ultra short) regimen. BMC Research Notes. 2009;2:165.

Dasgupta S, Sarkhel A, Jain A. Single loading dose of magnesium sulphate in severe preeclampsia and eclampsia-is it effective? a randomized prospective study. Obstet Gynecol Int J. 2015;2(6):59.

Winit P, Saropala N. Serum level of magnesium attained in magnesium sulphate therapy for severe preeclampsia. Asia Oceania J Obstet Gyn. 1993;194:387-90.

Andrea W. Prevention and treatment of eclamptic convulsions. Clinical Obstet Gyn. 1999;42:16-24.

Downloads

Published

2017-02-03

Issue

Section

Original Research Articles